Indoco Remedies declined 2.54% to Rs 255.40 after the U.S. Food and Drug Administration (USFDA) had inspected the company's manufacturing facility at Plant II (Sterile) located at Goa
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.